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Abstract
Background: Optical coherence tomography (OCT) is a simple, high-resolution technique to quantify the thickness of retinal
nerve fiber layer (RNFL), which provides an indirect measurement of axonal damage in multiple sclerosis (MS). This study
aimed to evaluate RNFL thickness in patients at presentation with clinically isolated syndromes (CIS) suggestive of MS.
Methodology: This was a cross-sectional study. Twenty-four patients with CIS suggestive of MS (8 optic neuritis [ON], 6
spinal cord syndromes, 5 brainstem symptoms and 5 with sensory and other syndromes) were prospectively studied. The
main outcome evaluated was RNFL thickness at CIS onset. Secondary objectives were to study the relationship between
RNFL thickness and MRI criteria for disease dissemination in space (DIS) as well as the presence of oligoclonal bands in the
cerebrospinal fluid.
Principal Findings: Thirteen patients had decreased RNFL thickness in at least one quadrant. Mean RNFL thickness was
101.67610.72 mm in retrobulbar ON eyes and 96.93610.54 in unaffected eyes. Three of the 6 patients with myelitis had at
least one abnormal quadrant in one of the two eyes. Eight CIS patients fulfilled DIS MRI criteria. The presence of at least one
quadrant of an optic nerve with a RNFL thickness at a P,5% cut-off value had a sensitivity of 75% and a specificity of 56%
for predicting DIS MRI.
Conclusions: The findings from this study show that axonal damage measured by OCT is present in any type of CIS; even in
myelitis forms, not only in ON as seen up to now. OCT can detect axonal damage in very early stages of disease and seems
to have high sensitivity and moderate specificity for predicting DIS MRI. Studies with prospective long-term follow-up would
be needed to establish the prognostic value of baseline OCT findings.
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Introduction
A clinically isolated syndrome (CIS) involving the optic nerve,
spinal cord, brainstem or other portions of the brain, is the most
frequent initial presentation of multiple sclerosis (MS). Several
studies have tried to identify the risk factors associated with the
development of clinically definite MS (CDMS) after a first acute
demyelinating attack [1–11]. The presence and extent of lesions on
baseline magnetic resonance imaging (MRI) of the brain is strongly
related to the probability of developing MS [1,2,5,9,10]. In
addition, due to its high sensitivity in detecting disease-related
abnormalities, MRI has been formally included in the diagnostic
work-up of MS patients, to exclude alternative diagnoses and aid in
the demonstration of disease dissemination in space (DIS) and time
(DIT), which are the main criteria for a diagnosis of CDMS [12,13].
Post-mortem [14,15] and MRI [16–18] studies have demon-
strated early axonal loss in MS patients. Since axonal damage is a
key contributor to the clinical manifestations of the disease and to
the development of clinical disability over time, biomarkers of
early axonal degeneration in patients at presentation with CIS
would therefore be of great interest.
Monitoring axonal loss has become a priority in MS. It has
recently demonstrated that analysis of the retinal nerve fiber layer
(RNFL) thickness may be useful to detect degenerative process in
the central nervous system [19,20]. Optical coherence tomography
(OCT) has emerged as a simple accurate noninvasive technique
that can be used to measure RNFL thickness. Several studies have
consistently demonstrated that OCT is a useful tool to detect
retinal axonal loss following an acute episode of optic neuritis
(ON), a very common, often initial symptom of MS [21–25]. In
addition, this technique can help to detect subclinical axonal loss,
as suggested by the demonstration of a decreased RFNL thickness
in fellow ON eyes or reduced RFNL thickness in MS patients
without a history of ON [26–28].
The aim of this study was to measure RNFL thickness in
patients at presentation with CIS suggestive of MS and to
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investigate the relationship between RNFL thickness abnormalities
and clinical manifestations at disease onset, MRI features
according to the International Panel (IP) criteria for DIS [14]
and cerebrospinal fluid (CSF) profile.
Methods
Ethics statement
The study was approved by the local Ethics Committee (CEIC
Hospital La Paz) and written informed consent was obtained from
all subjects. The study complies with the guidelines of the
Declaration of Helsinki.
Patients
All consecutive patients with a single episode of CIS attending
the Neurology Department of our center during 2008 were invited
to participate in this study.
The diagnosis of ON was based on clinical criteria, including
visual loss in the affected eye, relative afferent pupillary defect, a
visual field defect and pain that increases with eye movement [29].
Exclusion criteria included the presence of an ocular pathology
other than ON, intraocular pressure higher than 21 mmHg and a
refractive error greater than 5.0 diopters (D) of spherical
equivalent or 3.0 D of astigmatism in either eye. CIS with a
clinical onset other than an ON were diagnosed on the basis of
clinical criteria and, when needed, confirmed by the presence of
lesions on brain or spinal cord MRI. Appropriate investigations
were carried out as necessary to exclude alternative diagnoses, and
all patients were carefully interviewed for a previous demyelinating
event. Patients treated with corticosteroids for relapses before
OCT and lumbar puncture examination were not included.
All patients underwent a complete neurological examination
(within 7 days from symptoms onset) and neurological disability
was measured using the Expanded Disability Status Scale (EDSS)
[30]. Within the first two months from the attack, all the subjects
underwent lumbar puncture (whenever possible) and brain and
spinal cord MRI.
MRI
The following MRI sequences of the brain were acquired using
a 3 Tesla scanner (GE, USA): a) dual-echo axial variable echo fast
spin echo (FSE): repetition time (TR) = 2940 ms; first echo time
(TE) = 10 ms; second TE=110 ms; echo train length (ETL) = 16,
FOV=24, 44 slices, slice thickness = 3.0 mm, interleaved slices,
matrix = 2566256), b) axial 3D T1 Inversion recovery (IR) Prep:
first TE= 10 ms; T1= 750 ms; TR=10 ms, flip angle = 12,
FOV=24, slice thickness = 1 mm, 24 slices, matrix = 2406240),
c) axial fast fluid attenuated inversion recovery (FLAIR):
TR=9000, TE=95, T1= 2200; 3-mm-thick slices, FOV=24,
d) pre- and post-contrast T1-weighted conventional spin-echo
(TR=680 ms; TE= 14 ms, FOV=24, slice thickness = 3.0,
interleaved), 5 minutes after the intravenous administration of
0.1 mmol/kg gadopentetate dimeglumine.
The following sequences were also acquired for cervical cord: a)
sagittal T2 FSE (TE=99, TR=3000 ms; ETL=24; 4-mm-thick
slices with an interslice gap of 0.4 mm), b) sagittal T1 FSE
(TE=22, TR=575; ETL=3; 4-mm-thick slices with an interslice
gap of 0.4 mm), c) sagittal PD-weighted (TE=38, TR=2000;
TE= 38; ETL=8; 4-mm-thick slices with an interslice gap of
0.4 mm) and an oblique two-dimensional GE (TR=300;
FOV=20, 4-mm-thick slices with an interslice gap of 1 mm)
was a post-contrast T1w scan acquired for the cord.
Brain and cord MRI scans were assessed by two radiologists
blinded to neurological and ophthalmological examinations and
the fulfillment of IP criteria for DIS [31]. According to the original
IP criteria, the presence of two brain MRI lesions consistent with
MS together with positive oligoclonal bands (OCB) was also
considered as DIS.
Ophtalmologic evaluation
All study patients underwent a complete ophthalmologic
evaluation, including best corrected Snellen visual acuity (VA),
biomicroscopy of the anterior and posterior segments, funduscopy,
intraocular pressure measurement and Humphrey visual field
testing, using the Swedish Interactive Threshold Algorithm
standard 24-2 strategy (Carl Zeiss Meditec, Dublin, CA). Affection
of the visual field was defined according to the Optic Neuritis Trial
criteria [32] and quantified using mean deviation (MD) (expressed
in decibels [dB]).
OCT scanning was performed within the first month from the
onset of the clinical episode with the Stratus OCT (Carl Zeiss
Meditec, Dublin, CA) after induction of pharmacological
mydriasis. Image acquisition was performed with the Fast Retinal
Nerve Fiber Layer (RNFL) Thickness (3.46) and RNFL thickness
values (measured in micrometers [mm]) were obtained using the
RNFL Thickness Average Analysis protocol. The Stratus OCT
built-in software compares a color-coded graph that displays the
RNFL measurements with the age-matched data of a normalized
database. Assuming a normal distribution of the RNFL, the
thickest 5% of measurements are colored white (white .95%)
and the thinnest 1% of measurements fall in the red area.
Measurements in red are considered outside normal limits (red
,1%, outside normal limits). Five percent of measurements fall in
the yellow area or below (1%# yellow ,5%, suspect) and 90% of
measurements fall in the green area (5%# green #95%).
Thickness values falling into the green area are considered
normal. The yellow area marks thickness values that are 5% or
less than all thickness values measured in the normative database.
Thickness measurements in the red area are considered
pathologic.
Sensitivity and specificity were calculated for RNFL thickness
for the quadrant sectors at p,5% and p,1% cut-off values.
CIS patients were divided into two groups according to their
clinical onset: CIS onset with ON (CIS-ON) and CIS onset
without ON (CIS-nON). In CIS-ON patients, the eye which had
suffered ON was defined as affected eye and was studied
independently from the fellow eye. Left eyes of CIS-nON patients
and fellow eyes of CIS-ON patients were grouped as unaffected
eyes to include only one eye of each patient and therefore,
avoiding design bias.
Statistical analysis was performed using the SPSS 12.0 program
for Windows (SPSS Inc., Chicago, IL, USA). Visual acuity (VA)
was measured in Snellen and expressed as a decimal value, but it
was transformed to LogMAR system to be analyzed. VA was
considered normal when it was of 1 expressed by decimal scale or
0 by LogMAR system. The Shapiro-Wilk test was used to verify if
the distribution of variables values fit the normal distribution.
Nonparametric tests were applied since most variables were not
normally distributed. The Wilcoxon test was used to analyze
differences between the eyes of each patient. A Mann-Whitney test
was used for independent samples. The total level of significance
was set at 0.05.
Results
Twenty-four patients with CIS were recruited, including 8
(33%) patients with unilateral ON, 6 (25%) with spinal cord
syndrome (myelitis), 5 (21%) with brainstem symptoms and 5
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(21%) with sensory and other syndromes. There were thirteen
(54%) women and 11 (46%) men, with a median age of 38 years
(range 19–57 years). Their EDSS score ranged from 0.0 to 4.0,
with a median of 1.0.
Lumbar puncture was performed in 21 patients because three of
them refused. Oligoclonal IgG bands were found in 12 (57.1%)
patients and the IgG index was increased in 10 (47.6%) patients.
Eight patients (33%) fulfilled IP criteria for DIS, whereas 8
patients had normal brain MRI scans. Cervical MRI was
pathological in all 6 patients with spinal cord CIS and in two
patients with DIS.
Nine of the patients who underwent CSF analysis (37.5%)
showed two or more MRI lesions consistent with MS and positive
oligoclonal bands.
Two CIS-ON patients had an anterior and 6 a retrobulbar form
of ON, defined by the presence or absence of edema of the optic
nerve head respectively. In the 8 patients with ON-affected eyes,
mean VA was 0.36 (SD 0.31) and all presented affected visual
fields, with a MD of 214.62 dB (SD 7.82). All the fellow eyes of
CIS-ON patients had normal VA (p= 0.03) and visual fields were
affected in 5 out of 8 (62.5%), with a MD of 22.22 dB (SD 2.31)
(p = 0.01).
Visual acuity was normal in 21 out of 24 (87.5%) of unaffected
eyes; it was 0.8 in two and 0.5 in one eye. Eight (33.3%) unaffected
eyes of CIS-nON patients and ON patients had abnormal visual
fields, with MD of 22.64 dB (SD 4.82).
Visual acuity was normal in 21 out of 24 (87.5%) of unaffected
eyes; it was 0.8 in two and 0.5 in one eye. Five right eyes and 3 left
eyes had abnormal visual fields, with a MD of 22.22 dB (SD 2.31)
and 22.35 dB (SD 4.81), respectively.
RNFL thickness analysis provided the following results: 54.2%
of all patients and 56.3% of the CIS-nON patients presented at
least one quadrant of an optic nerve with a decreased RNFL
thickness. Mean RNFL thickness was 142.13 mm (SD 13.56) in
anterior ON eyes and it was 101.67 mm (SD 10.72) in retrobulbar
ON eyes (p = 0.05). Mean RNFL thickness was 96.93 (SD 10.54)
in unaffected eyes of CIS-nON patients and ON patients.
Table 1 shows mean RNFL thickness and the color assigned by
the age-normalized Stratus-OCT database for each group of eyes.
Three of the 6 patients with myelitis had at least one abnormal
quadrant in one of the two eyes. Three of the 8 (37.5%) ON
affected eyes and 6 of 24 (25%) unaffected eyes presented at least
one quadrant with a thickness at a p,5% cut-off value. Three of
24 (12.5%) unaffected eyes presented at least one quadrant with a
thickness at a p,1% cut-off value. When we analyzed the results
by patients, 13 (54.2%) and 7 (29.2%) patients had at least one
quadrant with a thickness at a p,5% and a p,1% cut-off values,
respectively.
Crosstabulation between OCT measures and MRI criteria and
alternative criteria (at least two MRI lesions and OCB presence)
for DIS are shown in Table 2. Eight CIS patients fulfilled DIS
MRI criteria and 9 patients met alternative criteria for DIS based
on MRI and OCB presence, Six out of 8 patients who fulfilled
MRI criteria for DIS presented at least one quadrant with a RNFL
thickness of less than 5% than all thickness values measured in the
normative database. The presence of at least one quadrant of an
optic nerve with a RNFL thickness at a p,5% cut-off value had a
sensitivity of 75% and a specificity of 56% for predicting DIS
according to the MRI Barkhof criteria. Specificity increased to
81% whereas sensitivity decreased to 50% when the cut-off value
was set at p,1%. Sensitivity decreased to 67% at the p,5% cut-
off value and to 33% at the p,1% cut-off value according to MIR
criteria and OCB presence. Specificity was 58% at the p,5% cut-
off value and increased to 67% at the p,1% cut-off value. Table 3
shows the sensibility and specificity for OCT findings according to
3/4 Barkhof criteria and alternative criteria based on MIR
evidence and OCB presence.
Discussion
In patients diagnosed with MS it has been demonstrated that
axonal loss occurs in the early stages of the disease. Therefore, a
large effort has been focused on early detection of patients with
high risk of developing MS at the first CIS in order to start early
immunomodulatory treatment to reduce the accumulation of
irreversible axonal loss.
OCT has demonstrated to be a useful tool to detect axonal loss
as a thinning of the RNFL following an initial episode of ON. To
our knowledge only one study have addressed the use of OCT on
patients with other types of CIS different from ON, like myelitis or
brainstem syndromes [21]. RNFL thickness increase in acute
anterior ON and progressive axonal loss in anterior and
retrobulbar ON has already been demonstrated [21,33]. Mean
Table 1. Mean RNFL thickness and its color assigned by the normalized Stratus-OCT database according to age and proportion of
eyes with at least one quadrant P,5% and P,1% cut-off values.
CIS-ON patients CIS-nON patients
Affected eyes Fellow eyes Right eyes Left eyes
(N=8) (N=8) (N=16) (N=16)
Mean RFNL thickness ± SD (mm) 101.67610.72 97.44613.53 92.5869.49 96.6769.21
RFNL thickness color, n (%)
White 0 (0) 0 (0) 0 (0) 0 (0)
Green 6 (75) 7 (87.5) 13 (81.3) 15 (93.8)
Yellow 0 (0) 1 (12.5) 2 (12.5) 1 (6.3)
Red 0 (0) 0 (0) 1 (6.3) 0 (0)
At least one quadrant at p,5% and p,1% cut-off values, n (%)
$1 quadrant p,5% 3 (37.5) 3 (37.5) 9 (56,3) 3 (18.8)
$1 quadrant P,5% 0 2 (25) 5 (31.3) 1 (6.3)
CIS: Clinically isolated syndrome; N: Number of eyes; ON: optic neuritis; RNFL: retinal nerve fiber layer.
doi:10.1371/journal.pone.0033907.t001
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RNFL thickness in the fellow non-affected eyes has ranged
between 92.9 mm (SD 11.4) to 99.8 mm (SD 32.50) in studies
focused on patients with isolated ON [23,24,34]. Statistical
significant differences have not been found when compared non-
affected eyes with control eyes, despite that their RNFL thickness
mean values were above 100 mm. [25,34–36]. Most studies have
been unable to demonstrate a significant thinning of the RNFL of
the fellow eyes when compared to healthy controls.
In our study, mean RNFL thickness was 101.67 mm and
97.44 mm in affected and fellow non affected eyes of the CIS-ON
patients respectively. The increased thickness obtained in affected
eyes could be explained by the presence of two anterior forms
since RNFL thickness increases in optic nerve edema [37,38].
Mean RNFL thickness was 92.58 and 97.44 mm in right CIS-nON
eyes and fellow ON-eyes respectively, suggesting subclinical retinal
axonal damage in CIS patients that occurs in the absence of optic
ON. The findings are consistent with those of previous studies that
described retinal axonal loss in patients with MS without previous
ON history when compared with a healthy control population
[27,28,39].
When we analyzed the color-code ordinal scale of RNFL
thickness, it was found that only 4 out of 48 eyes had a mean
RNFL thickness below the 5% cut-off value. This finding is
consistent with previous absolute values in control groups [25,34–
36]. However, in our study, 18 out of 48 eyes had at least one
quadrant in which RNFL thickness was below the 5% cut-off
values and RNFL thickness was below the 1% cut-off values in at
least one quadrant in 8 out of 48 eyes.These results suggest a mild
axonal loss present in CIS even within the first week after its
presentation. In brain studies, performed with proton magnetic
resonance spectroscopy, diffusion tensor MRI and magnetization
transfer, axonal damage has been demonstrated in patients
presenting with CIS at baseline [17,18,40].
To our knowledge, this is the first study to demonstrate early
retinal axonal layer thinning detected by OCT in patients who
have suffered from any type of CIS, including patients with
isolated myelitis. As expected, this thinning was mild but
identifiable by the software of the Stratus-OCT.
At the moment, the presence and extent of demyelinating lesions
in the MRI of patients with CIS is the main predictor of conversion
to CDMS. Retinal axonal thinning present at the time of CIS
presentation might be considered a signal of wider subclinical axonal
damage and early neurodegeneration. Since the current study was
conducted within the first two months of CIS presentation, we could
only consider OCT and MRI pathological findings as measures of
dissemination in space. Our results are in contrast to the only
available study using OCT on CIS patients [41] that did not
revealed retinal axonal loss at the earliest clinical stage ofMS and did
not predict conversion to MS at 6 months. Nevertheless, our study
cannot be directly compared with the abovementioned study due to
a substantial difference in disease duration. In this previous study,
patients had a disease duration up to one year whereas our study
population consisted of CIS patients who underwent OCT in the
first month and MRI and lumbar puncture in the first two months.
Additionally, the study population was very different to our CIS
group since 23% of the patients had clinically definite MS and 71%
presented dissemination in space according to the revisedMcDonald
criteria. Nevertheless, it was shown that 25% of the patients had
atrophy in at least one quadrant and 4 patients in two quadrants,
which reflects a slight axonal damage.
Six out of 8 patients who fulfilled DIS MRI criteria presented at
least one quadrant with less than 5% probability of normal RNFL
thickness. This provides a sensitivity of 75%, which decreased to
50% when a higher probability of real RNFL atrophy is
considered. However, when the cut-off value is set at p,1%,
specificity increased to 81%, since 13 out 16 patients who did not
fulfill DIS MRI criteria did not present any red-colored quadrant
either. These findings reflect that OCT seems to have high
sensitivity and moderate specificity for predicting DIS MRI. The
sensitivity of DIS MRI criteria was higher than the criteria based
on the finding of OCB in CSF plus two MRI lesions for DIS.
However, this alternative criterion based on OCB detection
yielded a slightly higher specificity than DIS-MRI at p,5% cut off
value. These data therefore reinforce the role of CSF study in MS
diagnosis.
Table 2. Crosstabulation between the two different criteria of spatial dissemination applied and OCT findings.
Quadrants ,5% Quadrants ,1%
DIS MRI criteria None $1 None $1 Total
Fulfilled 2 6 4 4 8
Not fulfilled 9 7 13 3 16
Total 11 13 17 7 24
Alternative criteria Quadrants ,5% Quadrants ,1%
(OCB+ at least two lesions in MRI) None $1 None $1 Total
Fulfilled 3 6 6 3 9
Not fulfilled 5 7 8 4 12
Total 8 13 14 7 21
DIS: dissemination in space; OCB: oligoclonal bands.
doi:10.1371/journal.pone.0033907.t002
Table 3. Sensibility and specificity for OCT findings according
to MIR Barkhof criteria and MIR and OCB criteria for DIS.
L Barkhof MIR criteria MIR and OCB criteria
,5% ,1% ,5% ,1%
Sensitivity (%) 75 50% 66.67% 33.33%
Specificity (%) 56.25% 81.25% 58.33% 66.67%
doi:10.1371/journal.pone.0033907.t003
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In our series, 57% of CIS patients presented positive OCB. This
result is in line with the proportions of CIS patients with positive
OCB reported in previous studies. Tintore et al. [11] found that
61% of patients had positive OCB, considering that 41% of those
with normal MRI did not undergo a lumbar puncture. Masjuan et
al. [7] reported that 63% of patients were positive for OCB (7 out
of 52 presented a normal scan and 7 had negative OCB) and Rojas
et al. [42] detected positive OCB in 53% of CIS patients.
The present study is limited to a relatively small sample size. A
larger sample was not achieved probably due to the fact that
patients were included in the study within the first 4 weeks after
the first event, and additionally, CSF and OCT had to be available
before the initiation of treatment with corticosteroids in order to
avoid false negative results owing to the effect of treatment.
However, patients usually receive treatment before OCT and CSF
analyses are performed when they arrive at the emergency room
and the time elapsed until both examinations are performed is
generally 6 weeks in routine clinical practice. In our study, patients
underwent OCT, MRI and CSF examination within the two first
months after the first event.
In the view of evidence, the relationship between RNFL
thinning in CIS and progression to MS is still unclear, since only
long-term follow-up will determine if these changes are clinically
relevant. Therefore, prospective studies with long-term follow-up
would be needed to establish the prognostic value of baseline OCT
findings in patients with CIS, when dissemination in time and
CDMS diagnosis could be determined.
In conclusion, axonal damage measured by OCT is present in
any type of CIS, even in myelitis forms, not only in ON as seen up
now. Although OCT has shown to detect axonal damage in very
early stages of disease, its capacity to predict conversion in CDMS
has not yet been demonstrated. Additional longitudinal studies
would establish its role as prognostic marker of neurological
disability. Thus, OCT could represent a potential tool that could
be used to detect and monitor axonal protective effects of new
neuroprotective therapies.
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